A team led by Professor Jeong Sang-hoon정상훈 of Korea Institute of Science and Technology한국과학기술연구원 (KIST) has developed a sensor technology that can measure calcium concentration in the body for the early diagnose of geriatric diseases.In most geriatric diseases, such as cancer, diabetes, heart disease, and intractable neurological diseases, there is an ongoing decrease in calcium in the endopla
Samsung Medical Center Cancer Ward삼성서울병원 암병원 has released “Healing U VR,” a virtual reality application to improve patients' distress, this month, SMC said Friday.This is the second app since the hospital released the "Samsung Seoul Hospital Cancer Hospital VR + App" in January. Smartphone users can access and download the application from the Google Play Store.Its goal is to help pati
One might have thought the question about the boundaries between states of consciousness and unconsciousness and how to quantify its different levels.A 2007 domestic film “Return” starring Kim Myung-min and American thriller “Awake” starring Hayden Christensen and Jessica Alba did just that; highlighting their state of consciousness during surgeries.Imagine the body paralyzed, but the brai
Medipost Co. announced Thursday that the monthly sales of its stem-cell treatment, Cartistem exceeded 200 bottles for the first time in July.Cartistem is the world’s first allogeneic stem cell drug, which won the marketing license from the Ministry of Food and Drug Safety in January 2012.It is a treatment for knee cartilage defects in patients with osteoarthritis caused by degenerative or
The Ministry of Food and Drug Safety (MFDS) has approved Revo-i, the first surgical robot system developed in Korea, officials said Thursday.Revo-i is a system in which a physician inserts a robot arm into the body of the patient after making a minimum incision, and surgeons can view three-dimensional images inside. Revo-i is used for general endoscopic surgery, including cholecystectomy and p
365mc Networks has signed a contract with Microsoft Korea한국마이크로소프트 for the research and development of liposuction artificial intelligence system.365mc is Korea's largest group of obesity treatment hospitals with 17 branches in Korea including two hospitals.The collaboration between the two companies to build a liposuction artificial intelligence system will make the most of the various wo
A consortium of Seoul National University Bundang Hospital분당서울대병원 (SNUBH), SK Telecomsk텔레콤 and EZCareTech이지케어텍 has successfully exported its integrated hospital information system (HIS) to the United States following the Middle East, the hospital said Thursday.Under the 24-billion won ($20 million) contract signed with Aurora Behavioral Healthcare of the U.S., the consortium will build the hos
The U.S. Food and Drug Administration (FDA) Wednesday expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) after the failure of other therapies. cGVHD is a life-threatening condition that occurs when cells from a stem cell transplant attack healthy cells in a patient’s tissues. Symptoms of cGVHD can be found in the sk
Salespeople are the most stressed group at most business corporations. Nowhere is this truer than in Korea’s pharmaceutical industry, in which drug makers producing similar medicines compete for even a razor-thin market share.YuYu Pharmaceuticals Inc.유유제약 wants their marketing staffs to do something other than maximizing revenue – to become stage performers.Responses from sales workers are
The U.S. Food and Drug Administration Tuesday approved Idhifa (compound: enasidenib) of Celgene Corp. for treating adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific isocitrate dehydrogenase-2 (IDH2) mutation.AML is cancer that forms in the bone marrow and shows an increased number of abnormal white blood cells in the bloodstream and bone marrow. The U.
MSD Korea said Tuesday that its Januvia (ingredient name: Citigliptin), Janumet (Sitagliptin+ Metformin) and Janumet XR (Surf Complex) had won approvals to be prescribed for patients with mild and moderate kidney problems.Januvia was the first DPP-4 inhibitor approved by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the Korean Ministry of Food and Drug Sa
Celltrion’s second antibody biosimilar product in Europe, Truxima, has registered rapid growth in the European market, the company said Tuesday.According to Mundipharma먼디파마, the European distributor for Celltrion셀트리온헬스케어, Truxima’s sales account for more than 30 percent of original drug sales in the United Kingdom and the Netherlands in July, and the market share has risen more than 10 percent
Lilly Korea said Tuesday it would release an advanced soft tissue sarcoma treatment Lartruvo (ingredient name: olaratumab) in the domestic market.Lartruvo is a monoclonal antibody proven to be clinically useful compared with doxorubicin monotherapy, which is the standard therapy for 40 years in the first treatment, in combination with doxorubicin.The Ministry of Food and Drug Safety식품의
Takeda Pharmaceuticals Korea한국다케다제약 said its Ninlarco (ingredient name: ixazomib) had received permission from the Ministry of Food and Drug Safety식품의약품안전처 to administer a combination therapy with Lenalidomide and Dexamethasone, in treating patients with multiple myeloma.Multiple myeloma is a disease caused by a type of immune cells called plasma cells. Even though it is a blood disease, its m
Celltrion Healthcare is preparing to release its third biosimilar Herzuma in the U.S. market, following Remsima and Truxima, the company said Monday.Herzuma is an anticancer, antibody biosimilar used for the treatment of breast cancer and stomach cancer. Its originator drug Herceptin was developed by the U.S. biotechnology corporation Genentech and is sold by Roche.Herceptin is a global bl
Pusan National University Hospital (PNUH) has introduced “voice keyboard,” an electronic chart voice input system, for the first time in Korea, hospital officials said Monday.Voice keyboard is a system that enables automatic documenting without needing the manual input of doctor's diagnosis, prescription, and image reading findings by using voice recognition technology. It also recognizes the
Domestic pharmaceutical companies’ coffers are overflowing with cash, thanks to sales growth in the second quarter of this year.Some pharmaceutical companies that have already announced earnings, such as Green Cross녹십자 and Celltrion Healthcare셀트리온, showed record-high quarterly earnings, and others will also likely follow their example.Hanmi Pharmaceuticals한미약품 (CEO Woo Jong-soo우정수) announc
North Korea’s healthcare system is as mysterious as the country itself. That makes a stark contrast to with its boisterous neighbor in the south, which Bloomberg said had the fourth most efficient healthcare system out of relatively developed 55 nations in 2016.Despite their silence, many allegations and rumors have been circulating about the appalling state facing North Korea currently. But t
The immunization rate of Korean children 36 months after birth is highest among countries that release such statistics, the Korea Centers for Disease Control and Prevention질병관리본부 (KCDC) said Thursday.According to a KCDC report surveying the immunization rate of children born in 2013, the vaccination rate of Korean children until they reach 36 months stood at 96.9 percent on average, 2-6 percen
Sanofi Pasteur Korea사노피파스퇴르, the vaccines division of the multinational pharmaceutical Sanofi사노피, has appointed Baptiste de Clarens as their new CEO, the company said Wednesday.De Clarens joined Sanofi Pasteur in 2006, where he was responsible for improving efficiency across marketing and operations across the company in Lyon, France. Since then, he has been in charge of business operations ac